EricCLarsenMD

Pediatric Hematology & Oncology • Scarborough, ME

Physician

Join to view full profile

Are you Dr. Larsen?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 43 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
100 Campus Dr
Unit 107
Scarborough, ME 04074
Phone+1 207-885-7565

Fax+1 207-885-7577
Is this information wrong?

Summary

Dr. Eric Larsen, MD is a pediatric hematologist/oncologist in Scarborough, Maine. He is currently licensed to practice medicine in Maine and New Hampshire. He is affiliated with Maine Medical Center.

Education & Training

Children's Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 1986 - 1989
Johns Hopkins UniversityResidency, Pediatrics, 1983 - 1986
University of Vermont College of MedicineClass of 1983

Certifications & Licensure

NH State Medical License 1990 - Present
ME State Medical License 2005 - 2026
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Start of enrollment: 2001 Oct 18
Active, not recruiting
Phase 3
Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma Start of enrollment: 2004 Sep 04
Completed
Phase 3
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia Start of enrollment: 2003 Dec 29
Completed
Phase 3
Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma Start of enrollment: 2004 Apr 01
Active, not recruiting
Phase 3
Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma Start of enrollment: 2005 Nov 14
Completed
Phase 3
Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors Start of enrollment: 2006 Jun 01
Completed
Phase 2
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor Start of enrollment: 2006 Oct 30
Active, not recruiting
Phase 3
Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma Start of enrollment: 2006 Dec 26
Completed
Phase 3
Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia Start of enrollment: 2007 Mar 01
Completed
Phase 3
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma Start of enrollment: 2007 Jan 22
Active, not recruiting
Phase 3
Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer Start of enrollment: 2003 Oct 13
Completed
Study of Kidney Tumors in Younger Patients Start of enrollment: 2006 Feb 27
Recruiting
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma Start of enrollment: 2000 Nov 06
Recruiting
Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma Start of enrollment: 1999 Mar 15
Completed
Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor Start of enrollment: 2009 Jul 13
Active, not recruiting
Phase 3
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 14
Active, not recruiting
Phase 3
Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2010 Aug 09
Completed
Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma Start of enrollment: 2010 Aug 09
Active, not recruiting
Phase 3
Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2011 Jun 20
Active, not recruiting
Phase 3
A Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND# 73789, NSC# 606869) in the Very High Risk Stratum Start of enrollment: 2012 Feb 01
Adcetris (Brentuximab Vedotin), Combination Chemotherapy, and Radiation Therapy in Treating Younger Patients With Stage IIB, IIIB and IV Hodgkin Lymphoma Start of enrollment: 2013 Aug 12
Active, not recruiting
Phase 2
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 01
Join now to see all

Publications & Presentations

PubMed

18 citations
Racial and ethnic disparities in childhood and young adult acute lymphocytic leukaemia: secondary analyses of eight Children's Oncology Group cohort trials.
Sumit Gupta, Yunfeng Dai, Zhiguo Chen, Lena E Winestone, David T Teachey, Kira Bona, Richard Aplenc, Karen R Rabin, Patrick Zweidler-McKay, Andrew J Carroll, Nyla A He...> ;The Lancet. Haematology. 2023 Feb 1
9 citations
Sex-based disparities in outcome in pediatric acute lymphoblastic leukemia: a Children's Oncology Group report.
Sumit Gupta, David T Teachey, Zhiguo Chen, Karen R Rabin, Kimberly P Dunsmore, Eric C Larsen, Kelly W Maloney, Leonard A Mattano Jr, Stuart S Winter, Andrew J Carroll,...> ;Cancer. 2022 May 1
21 citations
Excellent Outcome for Pediatric Patients With High-Risk Hodgkin Lymphoma Treated With Brentuximab Vedotin and Risk-Adapted Residual Node Radiation
Monika L. Metzger, Michael P. Link, Amy L. Billett, Jamie E. Flerlage, John T. Lucas, Belinda N. Mandrell, Matthew J. Ehrhardt, Nickhill Bhakta, Torunn I. Yock, Alison...> ;Journal of Clinical Oncology. 2021 Apr 7
14 citations
Association of GATA3 Polymorphisms With Minimal Residual Disease and Relapse Risk in Childhood Acute Lymphoblastic Leukemia.
Hui Zhang, Anthony P. Y. Liu, Meenakshi Devidas, Shawn H. R. Lee, Xueyuan Cao, Deqing Pei, Michael J. Borowitz, Brent L. Wood, Julie M. Gastier-Foster, Yunfeng Dai, El...> ;Journal of the National Cancer Institute. 2021 Apr 6
3 citations
Genetics of osteonecrosis in pediatric acute lymphoblastic leukemia and general populations.
Wenjian Yang, Meenakshi Devidas, Yiwei Liu, Colton Smith, Yunfeng Dai, Naomi J. Winick, Stephen P. Hunger, Mignon L. Loh, Elizabeth A. Raetz, Eric Larsen, William L. C...> ;Blood. 2021 Mar 18
90 citations
Impact of Asparaginase Discontinuation on Outcome in Childhood Acute Lymphoblastic Leukemia: A Report From the Children’s Oncology Group
Sumit Gupta, Cindy Wang, Elizabeth A. Raetz, Reuven J. Schore, Wanda L. Salzer, Eric Larsen, Kelly W. Maloney, Len A. Mattano, William L. Carroll, Naomi J. Winick, Ste...> ;Journal of Clinical Oncology. 2020 Apr 10
5 citations
No evidence that G6PD deficiency affects the efficacy or safety of daunorubicin in acute lymphoblastic leukemia induction therapy.
Katherine M. Robinson, Wenjian Yang, Seth E. Karol, Nancy Kornegay, Dennis W. Jay, Cheng Cheng, John K. Choi, Dario Campana, Ching-Hon Pui, Brent L. Wood, Michael J. B...> ;Pediatric Blood & Cancer. 2019 Jun 1
23 citations
Replacing cyclophosphamide/cytarabine/mercaptopurine with cyclophosphamide/etoposide during consolidation/delayed intensification does not improve outcome for pediatri...
Michael J. Burke, Wanda L. Salzer, Meenakshi Devidas, Yunfeng Dai, Lia Gore, Joanne M. Hilden, Eric Larsen, Karen R. Rabin, Patrick A. Zweidler-McKay, Michael J. Borow...> ;Haematologica. 2019 May 1
Health Status and Health-related Quality of Life Measurement in Pediatric Cancer Clinical Trials: An Examination of the DFCI 00-01 Acute Lymphoblastic Leukemia Protocol.
Rae, C.,Furlong, W.,Feeny, D.,Couchman, R.,Silverman, L.,Sallan, S.,Laverdiere, C.,Clavell, L.,Michon, B.,Kelly, K.,Larsen, E.,Pullenayegum, E.,Athale, U.,Barr, R.> ;J. Pediatr. Hematol. Oncol.. 2018 Jun 15
40 citations
Toxicity associated with intensive postinduction therapy incorporating clofarabine in the very high-risk stratum of patients with newly diagnosed high-risk B-lymphobla...
Wanda L. Salzer, Michael J. Burke, Meenakshi Devidas, Si Chen, Lia Gore, Eric Larsen, Michael J. Borowitz, Brent L. Wood, Nyla A. Heerema, Andrew J. Carroll, Joanne M....> ;Cancer. 2018 Mar 15
101 citations
TP53 Germline Variations Influence the Predisposition and Prognosis of B-Cell Acute Lymphoblastic Leukemia in Children.
Maoxiang Qian, Xueyuan Cao, Meenakshi Devidas, Wenjian Yang, Cheng Cheng, Yunfeng Dai, Andrew J. Carroll, Nyla A. Heerema, Hui Zhang, Takaya Moriyama, Julie M. Gastier...> ;Journal of Clinical Oncology. 2018 Jan 4
12 citations
Cost comparison by treatment arm and center-level variations in cost and inpatient days on the phase III high-risk B acute lymphoblastic leukemia trial AALL0232.
Amanda M. DiNofia, Alix E. Seif, Meenakshi Devidas, Yimei Li, Matthew Hall, Yuan-Shung Huang, Viviane C. Cahen, Stephen P. Hunger, Naomi J. Winick, William L. Carroll,...> ;Cancer Medicine. 2018 Jan 1
2 citations
Reply to I.J. Cohen
Kristina K. Hardy, Leanne Embry, John A. Kairalla, Shanjun Helian, Meenakshi Devidas, F. Daniel Armstrong, Stephen P. Hunger, William L. Carroll, Eric Larsen, Elizabet...> ;Journal of Clinical Oncology. 2017 Oct 18
31 citations
Neurocognitive Functioning of Children Treated for High-Risk B-Acute Lymphoblastic Leukemia Randomly Assigned to Different Methotrexate and Corticosteroid Treatment St...
Kristina K. Hardy, Leanne Embry, John A. Kairalla, Shanjun Helian, Meenakshi Devidas, Daniel Armstrong, Stephen P. Hunger, William L. Carroll, Eric Larsen, Elizabeth A...> ;Journal of Clinical Oncology. 2017 Jul 3
26 citations
Genetics of ancestry-specific risk for relapse in acute lymphoblastic leukemia
Seth E. Karol, Eric C. Larsen, C. Cheng, Xueyuan Cao, Wenjian Yang, Laura B. Ramsey, Christian A. Fernandez, Joseph R. McCorkle, Steven W. Paugh, Robert J Autry, Elixa...> ;Leukemia. 2017 Jan 18
241 citations
Dexamethasone and High-Dose Methotrexate Improve Outcome for Children and Young Adults With High-Risk B-Acute Lymphoblastic Leukemia: A Report From Children’s Oncology...
Eric C. Larsen, Meenakshi Devidas, Si Chen, Wanda L. Salzer, Elizabeth A. Raetz, Mignon L. Loh, Leonard A. Mattano, Catherine H. Cole, Alisa L. Eicher, Maureen Haugan,...> ;Journal of Clinical Oncology. 2016 Sep 27
65 citations
Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic Leukemia
Chengcheng Liu, Wenjian Yang, Meenakshi Devidas, Cheng Cheng, Deqing Pei, Colton Smith, William L. Carroll, Elizabeth A. Raetz, W. Paul Bowman, Eric C. Larsen, Kelly W...> ;Journal of Clinical Oncology. 2016 Sep 27
47 citations
Genetic risk factors for the development of osteonecrosis in children under age 10 treated for acute lymphoblastic leukemia
Seth E. Karol, Leonard A. Mattano, Wenjian Yang, Kelly W. Maloney, Colton Smith, Chengcheng Liu, Laura B. Ramsey, Christian A. Fernandez, Tamara Chang, Geoffrey Neale,...> ;Blood. 2015 Dec 3
119 citations
Germline genetic variation in ETV6 and risk of childhood acute lymphoblastic leukaemia: a systematic genetic study
Takaya Moriyama, Monika L. Metzger, Gang Wu, Rina Nishii, Maoxiang Qian, Meenakshi Devidas, Wenjian Yang, Cheng Cheng, Xueyuan Cao, Emily Quinn, Susana C. Raimondi, Ju...> ;The Lancet. Oncology. 2015 Dec 1
89 citations
Genetics of glucocorticoid-associated osteonecrosis in children with acute lymphoblastic leukemia
Seth E. Karol, Wenjian Yang, Sara L. Van Driest, Tamara Chang, Sue C. Kaste, Erica Bowton, Melissa A. Basford, Lisa Bastarache, Dan M. Roden, Joshua C. Denny, Eric Lar...> ;Blood. 2015 Oct 8
Impact of hemochromatosis gene mutations on cardiac status in doxorubicin-treated survivors of childhood high-risk leukemia.
Lipshultz, S. E.,Lipsitz, S. R.,Kutok, J. L.,Miller, T. L.,Colan, S. D.,Neuberg, D. S.,Stevenson, K. E.,Fleming, M. D.,Sallan, S. E.,Franco, V. I.,Henkel, J. M.,Asseli...> ;Cancer. 2013 Oct 1
123 citations
Tyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group TARGET Project
Mignon L. Loh, Jinghui Zhang, Richard C. Harvey, Kathryn G. Roberts, Debbie Payne-Turner, Huining Kang, Gang Wu, Xiang Chen, Jared Becksfort, Michael N. Edmonson, Kenn...> ;Blood. 2013 Jan 17
104 citations
Continuous Versus Bolus Infusion of Doxorubicin in Children With ALL: Long-term Cardiac Outcomes.
Steven E. Lipshultz, Tracie L. Miller, Stuart R. Lipsitz, Donna Neuberg, Suzanne E. Dahlberg, Steven D. Colan, Lewis B. Silverman, Jacqueline M. Henkel, Vivian L. Fran...> ;Pediatrics. 2012 Dec 1
69 citations
Association between radiotherapy vs no radiotherapy based on early response to VAMP chemotherapy and survival among children with favorable-risk Hodgkin lymphoma.
Monika L. Metzger, Howard J. Weinstein, Melissa M. Hudson, Amy L. Billett, Eric C. Larsen, Alison M. Friedmann, Scott C. Howard, Sarah S. Donaldson, Matthew J. Krasin,...> ;JAMA. 2012 Jun 27
16 citations
Migration and remyelination by oligodendrocyte progenitor cells transplanted adjacent to focal areas of spinal cord inflammation
Jing-Hua Piao, Eric C. Larsen, Yoichi Kondo, Ian D. Duncan> ;Journal of Neuroscience Research. 2011 Nov 1
Join now to see all

Hospital Affiliations

Maine Medical CenterPortland, Maine